FMP
Recro Pharma, Inc.
REPH
NASDAQ
Inactive Equity
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
2.09 USD
-0.00999999 (-0.478%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Ms. Geraldine Henwood
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.recrocdmo.comexchange
NASDAQ
Description
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was...
CIK
0001588972
ISIN
US75629F1093
CUSIP
75629F109
Address
490 Lapp Rd
Phone
14843952400
Country
US
Employee
185
IPO Date
Mar 7, 2014
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
REPH Financial Summary
CIK
0001588972
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
75629F109
ISIN
US75629F1093
Country
US
Price
2.09
Beta
1.12
Volume Avg.
128.49k
Market Cap
177.42M
Shares
-
52-Week
2.0001-2.14
DCF
2.58
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8.04
P/B
-
Website
https://www.recrocdmo.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest REPH News
It looks like there's no news available.
